H.R. 9495 - Department of Defense Appropriations Act, 2027; H.R. 9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; S. 4632 - Lankford-Hassan Prevent Government Shutdowns Act of 2026; Issues related to funding for NIH; Issues related to funding for CDC; Issues related to funding for CMS; Issues related to funding for Alzheimer's
H.R. 3501, S. 1799 - a bill to amend title XVIII of the Social Security Act to direct CMS to include certain standardized tests for cognitive impairment detection in the Medicare annual wellness visit and initial preventive physical examination; H.R. 5371 - FY2026 Continuing Appropriations and Extensions Act; H.R. 6799 - To amend title II of the Social Security Act to eliminate the waiting periods for disability insurance benefits and Medicare coverage for individuals with young-onset Alzheimer's, and for other purposes; H.R. 6130, S. 3267 - ASAP Act; H.R. 9418 - Access to Innovative Treatments Act of 2026; H.R. 9495 - Department of Defense Appropriations Act, 2027; H.R. 9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; Durbin Cures Act; Issues related to the Affordable Care Act, Medicaid and comprehensive healthcare; Issues related to implementation of PL-119-21; Issues related to coverage for biomarker testing
H.R. 247, S. 46 - Health Care Affordability Act of 2025; H.R. 9495 - Department of Defense Appropriations Act, 2027; H.R. 9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; H.R. 9418 - Access to Innovative Treatments Act of 2026; H.R. 6799 - To amend title II of the Social Security Act to eliminate the waiting periods for disability insurance benefits and Medicare coverage for individuals with young-onset Alzheimer's, and for other purposes; Issues related to improving strategies for early detection and prevention of Alzheimers; Issues related to the Affordable Care Act, Medicaid and comprehensive healthcare; Issues related to implementation of PL-119-21; Issues related to coverage for biomarker testing